PAPER Agholme L, Nath S, Domert J, Marcusson J, Kågedal K, Hallbeck M
SEARCH RESULTS
331254 RESULTS
PAPER Brenowitz WD, Monsell SE, Schmitt FA, Kukull WA, Nelson PT
Hippocampal sclerosis of aging is a key Alzheimer's disease mimic: clinical-pathologic correlations and comparisons with both alzheimer's disease and non-tauopathic frontotemporal lobar degeneration.
J Alzheimers Dis. 2014;39(3):691-702. PubMed: 24270205PAPER Arodin L, Lamparter H, Karlsson H, Nennesmo I, Björnstedt M, Schröder J, Fernandes AP
Alteration of thioredoxin and glutaredoxin in the progression of Alzheimer's disease.
J Alzheimers Dis. 2014;39(4):787-97. PubMed: 24270206PAPER Murray PS, Kirkwood CM, Gray MC, Fish KN, Ikonomovic MD, Hamilton RL, Kofler JK, Klunk WE, Lopez OL, Sweet RA
Hyperphosphorylated tau is elevated in Alzheimer's disease with psychosis.
J Alzheimers Dis. 2014;39(4):759-73. PubMed: 24270207PAPER Solfrizzi V, Panza F
Mediterranean diet and cognitive decline. A lesson from the whole-diet approach: what challenges lie ahead?
J Alzheimers Dis. 2014;39(2):283-6. PubMed: 24270209PAPER Salcedo-Tello P, Hernández-Ortega K, Arias C
Susceptibility to GSK3β-induced tau phosphorylation differs between the young and aged hippocampus after Wnt signaling inhibition.
J Alzheimers Dis. 2014;39(4):775-85. PubMed: 24270208PAPER Patocskai AT, Pákáski M, Vincze G, Fullajtár M, Szimjanovszki I, Drótos G, Boda K, Janka Z, Kálmán J
Is there any difference between the findings of Clock Drawing Tests if the clocks show different times?
J Alzheimers Dis. 2014;39(4):749-57. PubMed: 24270210PAPER Phung KT, Waldorff FB, Buss DV, Eckermann A, Keiding N, Rishøj S, Siersma V, Sørensen J, Søgaard R, Sørensen LV, Vogel A, Waldemar G
A three-year follow-up on the efficacy of psychosocial interventions for patients with mild dementia and their caregivers: the multicentre, rater-blinded, randomised Danish Alzheimer Intervention Study (DAISY).
BMJ Open. 2013 Nov 21;3(11):e003584. PubMed: 24270834PAPER Han J, Jung S, Jang J, Kam TI, Choi H, Kim BJ, Nah J, Jo DG, Nakagawa T, Nishimura M, Jung YK
OCIAD2 activates γ-secretase to enhance amyloid β production by interacting with nicastrin.
Cell Mol Life Sci. 2014 Jul;71(13):2561-76. Epub 2013 Nov 24 PubMed: 24270855PAPER Pryce Roberts A, Robertson NP
Possible treatment targets in Alzheimer's disease.
J Neurol. 2013 Dec;260(12):3193-6. PubMed: 24270945PAPER Neltner JH, Abner EL, Baker S, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD, Hammack E, Kukull WA, Brenowitz WD, Van Eldik LJ, Nelson PT
Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing.
Brain. 2014 Jan;137(Pt 1):255-67. Epub 2013 Nov 21 PubMed: 24271328PAPER Polydoro M, Dzhala VI, Pooler AM, Nicholls SB, McKinney AP, Sanchez L, Pitstick R, Carlson GA, Staley KJ, Spires-Jones TL, Hyman BT
Soluble pathological tau in the entorhinal cortex leads to presynaptic deficits in an early Alzheimer's disease model.
Acta Neuropathol. 2014 Feb;127(2):257-70. Epub 2013 Nov 24 PubMed: 24271788PAPER Nagao S, Yokota O, Ikeda C, Takeda N, Ishizu H, Kuroda S, Sudo K, Terada S, Murayama S, Uchitomi Y
Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders.
Eur Arch Psychiatry Clin Neurosci. 2014 Jun;264(4):317-31. Epub 2013 Nov 23 PubMed: 24272318PAPER Streit WJ, Xue QS, Braak H, del Tredici K
Presence of severe neuroinflammation does not intensify neurofibrillary degeneration in human brain.
Glia. 2014 Jan;62(1):96-105. Epub 2013 Nov 4 PubMed: 24272705PAPER Beitnere U, van Groen T, Kumar A, Jansone B, Klusa V, Kadish I
Mildronate improves cognition and reduces amyloid-β pathology in transgenic Alzheimer's disease mice.
J Neurosci Res. 2014 Mar;92(3):338-46. Epub 2013 Nov 22 PubMed: 24273007Current Filters
No filters selected